Related Experiment Video
Updated: Jul 20, 2026

Minimal Erythema Dose MED Testing
Published on: May 28, 2013
Optimizing Narrowband UVB Phototherapy: Is It More Challenging for Your Older Patients?
Sarah W Matthews1, Karen J Sherman1, Stephanie Binick1
1Drs. Matthews and Chien are from Kaiser Permanente Washington Dermatology, Bellevue. Dr. Matthews also is from the University of Washington School of Nursing, Seattle. Dr. Chien also is from the University of Washington School of Medicine, Seattle. Dr. Sherman is from Kaiser Permanente Washington Health Research Institute, Seattle. Ms. Binick is from the University of Washington Medical Center, Dermatology Clinic at UWMC-Roosevelt, Seattle.
Abstract:
Narrowband UVB (NB-UVB) phototherapy remains versatile, safe, and efficacious for multiple dermatologic conditions even with recent pharmacologic treatment advances. Polypharmacy contributes to prescribers pursuing phototherapy as a nonpharmacologic treatment, but some wonder if it is as effective and safe for older patients. This study aimed to determine if NB-UVB is equally effective in both older and younger adults treated with the same protocol and to examine the association between photosensitizing medications, clearance, and erythema rates in older vs younger adults.
Related Concept Videos
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acne Infection

